Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
327 Leser
Artikel bewerten:
(1)

Legacy ER & Urgent Care Now Offering Federally Approved COVID-19 Antibody Testing

Company warns public to use only antibody tests that have been granted Emergency Use Authorization by the FDA

FRISCO, TX / ACCESSWIRE / April 29, 2020 / Legacy ER & Urgent Care, the national leader in combined emergency-room and urgent-care facilities that operate under one roof, is one of the first in the Dallas-Fort Worth area to offer one of the seven COVID-19 antibody test that has been granted Emergency Use Authorization, also known as EUA by the Federal Drug Administration, also known as FDA. The COVID-19 Antibody test is Abbott test for IgG, also known as Immunoglobulin G - a type of antibody. The test received its EUA authorization on April 26 by the FDA. The COVID-19 antibody determines if an individual has been infected with the disease. COVID-19 antibody testing is available at Legacy ER & Urgent Care's six North Texas locations.

A visit for the COVID-19 antibody test, also known as a coronavirus serological antibody test, at Legacy ER & Urgent Care typically takes no more than 30 minutes to complete. All patients will be screened curbside. Asymptomatic patients will proceed indoors and COVID-19 related symptomatic patients will stay inside their vehicles via temporary curbside service. For patients just wanting the COVID-19 antibody test, 2ml of blood is drawn. The blood is then sent to a partner lab for testing. Results are available within two to five days.

Patients don't need to have -- or have had -- any COVID-19 symptoms to be tested. Patient responsibility for testing and COVID-19 related visits are covered by many insurance plans. In-Network Insurance Providers are listed at LegacyER.com/Insurance. To determine specific plan coverage for COVID-19 related visits, patients are advised to contact their insurance company for guidance.

"Since the beginning of April, more than 100 antibody tests have shown up in the marketplace that are non-FDA authorized. Many of these COVID-19 tests have turned out not to be accurate nor approved via the FDA's EUA process. Many give patients false positives - meaning that the patient is told that they have COVID-19 antibodies when they actually don't. This is the exact reason why Legacy ER & Urgent Care delayed our antibody testing. The safety of patients is our number one priority. We waited for the FDA to issue an EUA," said Jay Woody, MD, FACEP, chief medical officer of Intuitive Health and a co-founder of Legacy ER & Urgent Care.

"The problem with the hundred or so COVID-19 antibody tests in the market right now is that they are not FDA EUA approved so the validity of the results is questionable," Woody said. "Many of these unapproved tests involve a finger prick with results in 15 minutes. Our test takes two to five days to receive results. While we understand the public's desire to have a test with quick results, we make sure that any COVID-19 tests we provide, we can trust their results."

On Sunday, CNN reported that the FDA said in a statement, "FDA will continue to consider the risks and benefits of our policies as the emergency evolves and adjust as necessary. FDA is constantly evaluating whether our policy needs to change based on new information to protect the public health."

The COVID-19 antibody test is available every day from 7 a.m. to 9 p.m. While no appointments are necessary to receive testing, new patients are encouraged to pre-register online. Each Legacy ER & Urgent Care facility remains open, safe and clean for all patients. To answer additional questions about Legacy ER & Urgent Care's procedures regarding COVID-19, visit them online.

ABOUT LEGACY ER & URGENT CARE
Legacy ER & Urgent Care is a combined emergency room and urgent-care center under one roof. The patient-centered retail-care model is built on a proven business system focused on concierge-level customer service and transparency. Each location has on-site lab equipment, a radiology suite with X-ray and multislice CT scanners and is open 24 hours a day, seven days a week. Every patient is seen by an ER-trained physician. Patients only pay for the care they need, as objective criteria determine whether emergency or urgent care is required. This proven model establishes a cost-effective, personal and time-efficient way to deliver high-quality medical services at the appropriate cost, garnering long-term patient loyalty. Legacy ER & Urgent Care currently operates six locations in North Texas, in Allen, Coppell, East Frisco, West Frisco, McKinney and North Richland Hills. Legacy ER & Urgent Care is an Intuitive Health company. For more information, visit LegacyER.com, follow the company's blog, or follow them on social media on Facebook and Instagram.

Media Contact:
Jo Trizila, TrizCom PR
Office: 972-247-1369
Cell/Text: 214-232-0078
Email: Jo@TrizCom.com

SOURCE: Legacy ER & Urgent Care



View source version on accesswire.com:
https://www.accesswire.com/587609/Legacy-ER-Urgent-Care-Now-Offering-Federally-Approved-COVID-19-Antibody-Testing

© 2020 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.